Real Time Touch



new TOP 200 Companies filing patents this week

new Companies with the Most Patent Filings (2010+)




Real Time Touch

Abbvie Biotechnology Ltd patents


Recent patent applications related to Abbvie Biotechnology Ltd. Abbvie Biotechnology Ltd is listed as an Agent/Assignee. Note: Abbvie Biotechnology Ltd may have other listings under different names/spellings. We're not affiliated with Abbvie Biotechnology Ltd, we're just tracking patents.

ARCHIVE: New 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 | Company Directory "A" | Abbvie Biotechnology Ltd-related inventors


Wearable automatic injection device for controlled delivery of therapeutic agents

Exemplary embodiments provide wearable automatic injection devices for subcutaneously injecting a therapeutic agent into a patient's body at controlled rates, for example, in a single bolus. Exemplary embodiments provide methods for assembling wearable automatic injection devices for subcutaneously injecting a therapeutic agent into a patient's body at controlled rates. ... Abbvie Biotechnology Ltd

Automatic injection devices having overmolded gripping surfaces

Exemplary embodiments provide automatic injection devices, housing components for automatic injection devices and methods for fabricating the same. An exemplary housing of an automatic injection device may be overmolded with one or more gripping surfaces to facilitate gripping and manipulation of the automatic injection device by a user when performing an injection. ... Abbvie Biotechnology Ltd

Methods and compositions for treatment of skin disorders

The invention provides methods and compositions for the treatment of a skin disorder associated with detrimental tnfα activity, such as psoriasis. The invention includes methods for treating a skin disorder associated with detrimental tnfα activity, such as psoriasis, in a subject who has failed or lost response to prior biologic therapy, such as prior administration of etanercept. ... Abbvie Biotechnology Ltd

Purified antibody composition

The invention provides a method for producing a host cell protein-(hcp) reduced antibody preparation from a mixture comprising an antibody and at least one hcp, comprising an ion exchange separation step wherein the mixture is subjected to a first ion exchange material, such that the hcp-reduced antibody preparation is obtained.. . ... Abbvie Biotechnology Ltd

Uses and compositions for treatment of psoriatic arthritis

The invention provides methods, uses and compositions for the treatment of psoriatic arthritis. The invention describes methods and uses for treating psoriatic arthritis, wherein a tnfα inhibitor, such as a human tnfα antibody, or antigen-binding portion thereof, is used to psoriatic arthritis in a subject. ... Abbvie Biotechnology Ltd

Automatic injection device

An automatic injection device for providing a injection is disclosed. The device includes a housing having a distal end operable by a user and an open proximal end for placement at an injection site. ... Abbvie Biotechnology Ltd

Formulation of human antibodies for treating tnf-alpha associated disorders

A liquid aqueous pharmaceutical formulation is described which has a high protein concentration, a ph of between about 4 and about 8, and enhanced stability.. . ... Abbvie Biotechnology Ltd

Uses and compositions for treatment of rheumatoid arthritis

The invention provides methods, uses and compositions for the treatment of rheumatoid arthritis. The invention describes methods and uses for treating rheumatoid arthritis wherein a tnfα inhibitor, such as a human tnfα antibody, or antigen-binding portion thereof. ... Abbvie Biotechnology Ltd

Formulation of human antibodies for treating tnf-alpha associated disorders

A liquid aqueous pharmaceutical formulation is described which has a high protein concentration, a ph of between about 4 and about 8, and enhanced stability.. . ... Abbvie Biotechnology Ltd

Purified antibody composition

The invention provides a method for producing a host cell protein-(hcp) reduced antibody preparation from a mixture comprising an antibody and at least one hcp, comprising an ion exchange separation step wherein the mixture is subjected to a first ion exchange material, such that the hcp-reduced antibody preparation is obtained.. . ... Abbvie Biotechnology Ltd

Use of tnfalpha antibody for treatment of hidradenitis suppurativa (hs)

The invention provides methods, uses and compositions for the treatment of hidradenitis suppurativa. The invention describes methods and uses for treating hidradenitis suppurativa, wherein a tnfα inhibitor, such as a human tnfα antibody, or antigen-binding portion thereof, is used to treat hidradenitis suppurativa in a subject. ... Abbvie Biotechnology Ltd

Formulation of human antibodies for treating tnf-alpha associated disorders

A liquid aqueous pharmaceutical formulation is described which has a high protein concentration, a ph of between about 4 and about 8, and enhanced stability.. . ... Abbvie Biotechnology Ltd

Multiple-variable dose regimen for treating tnfalpha-related disorders

Multiple-variable dose methods for treating tnfα-related disorders, including crohn's disease and psoriasis, comprising administering tnfα inhibitors, including tnfα antibodies, are described. Multiple-variable dose methods include administration of a tnf-inhibitor in an induction or loading phase followed by administration of the agent in a maintenance or treatment phase, wherein the tnf-inhibitor is administered in a higher dosage during the induction phase.. ... Abbvie Biotechnology Ltd

Multiple-variable dose regimen for treating tnfalpha-related disorders

Multiple-variable dose methods for treating tnfα-related disorders, including crohn's disease and psoriasis, comprising administering tnfα inhibitors, including tnfα antibodies, are described. Multiple-variable dose methods include administration of a tnf-inhibitor in an induction or loading phase followed by administration of the agent in a maintenance or treatment phase, wherein the tnf-inhibitor is administered in a higher dosage during the induction phase.. ... Abbvie Biotechnology Ltd








ARCHIVE: New 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009



###

This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. Freshpatents.com is not affiliated or associated with Abbvie Biotechnology Ltd in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Abbvie Biotechnology Ltd with additional patents listed. Browse our Agent directory for other possible listings. Page by FreshPatents.com

###